These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21609773)

  • 1. Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methods.
    Syvänen S; de Lange EC; Tagawa Y; Schenke M; Molthoff CF; Windhorst AD; Lammertsma AA; Voskuyl RA
    Neuroimage; 2011 Aug; 57(3):928-37. PubMed ID: 21609773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
    Syvänen S; Labots M; Tagawa Y; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA
    J Nucl Med; 2012 Dec; 53(12):1974-83. PubMed ID: 23143088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography.
    Liefaard LC; Ploeger BA; Molthoff CF; Boellaard R; Lammertsma AA; Danhof M; Voskuyl RA
    Mol Imaging Biol; 2005; 7(6):411-21. PubMed ID: 16328648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography and target-controlled infusion for precise modulation of brain drug concentration.
    Eriksson O; Josephsson R; Långstrom B; Bergström M
    Nucl Med Biol; 2008 Apr; 35(3):299-303. PubMed ID: 18355685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
    Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography.
    Liefaard LC; Ploeger BA; Molthoff CF; de Jong HW; Dijkstra J; van der Weerd L; Lammertsma AA; Danhof M; Voskuyl RA
    Epilepsia; 2009 Jan; 50(1):88-98. PubMed ID: 18727682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
    Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.
    Tantawy MN; Jones CK; Baldwin RM; Ansari MS; Conn PJ; Kessler RM; Peterson TE
    Nucl Med Biol; 2009 Nov; 36(8):931-40. PubMed ID: 19875049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
    Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
    Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
    Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
    Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil.
    Odano I; Halldin C; Karlsson P; Varrone A; Airaksinen AJ; Krasikova RN; Farde L
    Neuroimage; 2009 Apr; 45(3):891-902. PubMed ID: 19136064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET measurement of "GABA shift" in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [
    Kim W; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2017 Feb; 45():30-34. PubMed ID: 27886620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of 2'-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET.
    Mitterhauser M; Wadsak W; Wabnegger L; Mien LK; Tögel S; Langer O; Sieghart W; Viernstein H; Kletter K; Dudczak R
    Nucl Med Biol; 2004 Feb; 31(2):291-5. PubMed ID: 15013496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurement of the affinity and density of metabotropic glutamate receptor subtype 1 in rat brain using 18F-FITM in small-animal PET.
    Yamasaki T; Fujinaga M; Kawamura K; Yui J; Hatori A; Ohya T; Xie L; Wakizaka H; Yoshida Y; Fukumura T; Zhang MR
    J Nucl Med; 2012 Oct; 53(10):1601-7. PubMed ID: 22915159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.
    Feng L; Svarer C; Madsen K; Ziebell M; Dyssegaard A; Ettrup A; Hansen HD; Lehel S; Yndgaard S; Paulson OB; Knudsen GM; Pinborg LH
    Biomed Res Int; 2016; 2016():9132840. PubMed ID: 27123457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of benzodiazepine receptors in human brain using the partial saturation method.
    Delforge J; Spelle L; Bendriem B; Samson Y; Bottlaender M; Papageorgiou S; Syrota A
    J Nucl Med; 1996 Jan; 37(1):5-11. PubMed ID: 8544001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomography.
    Atack JR; Scott-Stevens P; Beech JS; Fryer TD; Hughes JL; Cleij MC; Baron JC; Clark JC; Hargreaves RJ; Aigbirhio FI
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1030-7. PubMed ID: 17164474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microPET comparison of the effects of etifoxine and diazepam on [(11)C]flumazenil uptake in rat brains.
    Bouillot C; Bonnefoi F; Liger F; Zimmer L
    Neurosci Lett; 2016 Jan; 612():74-79. PubMed ID: 26644334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.
    Sossi V; Holden JE; Topping GJ; Camborde ML; Kornelsen RA; McCormick SE; Greene J; Studenov AR; Ruth TJ; Doudet DJ
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1407-15. PubMed ID: 17245418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.